These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3739367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
    Zysset T, Zeugin T, Küpfer A.
    Biochem Pharmacol; 1988 Aug 15; 37(16):3155-60. PubMed ID: 3401246
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.
    Schmid B, Bircher J, Preisig R, Küpfer A.
    Clin Pharmacol Ther; 1985 Dec 15; 38(6):618-24. PubMed ID: 4064464
    [Abstract] [Full Text] [Related]

  • 4. Dextromethorphan metabolism in Jordanians: dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation.
    Irshaid YM, al-Hadidi HF, Latif A, Awwadi F, al-Zoubi M, Rawashdeh NM.
    Eur J Drug Metab Pharmacokinet; 1996 Dec 15; 21(4):301-7. PubMed ID: 9074894
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phenotyping polymorphic drug metabolism in the French Caucasian population.
    Jacqz E, Dulac H, Mathieu H.
    Eur J Clin Pharmacol; 1988 Dec 15; 35(2):167-71. PubMed ID: 3191936
    [Abstract] [Full Text] [Related]

  • 10. Methoxyphenamine and dextromethorphan as safe probes for debrisoquine hydroxylation polymorphism.
    Roy SD, Hawes EM, Hubbard JW, McKay G, Midha KK.
    Lancet; 1984 Dec 15; 2(8416):1393. PubMed ID: 6150386
    [No Abstract] [Full Text] [Related]

  • 11. Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children.
    Evans WE, Relling MV, Petros WP, Meyer WH, Mirro J, Crom WR.
    Clin Pharmacol Ther; 1989 May 15; 45(5):568-73. PubMed ID: 2721111
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.
    Küpfer A, Schmid B, Preisig R, Pfaff G.
    Lancet; 1984 Sep 01; 2(8401):517-8. PubMed ID: 6147572
    [No Abstract] [Full Text] [Related]

  • 15. Polymorphism of debrisoquine and mephenytoin hydroxylation among Estonians.
    Kiivet RA, Svensson JO, Bertilsson L, Sjöqvist F.
    Pharmacol Toxicol; 1993 Feb 01; 72(2):113-5. PubMed ID: 8474964
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dextromethorphan O-demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450 db1 activity.
    Dayer P, Leemann T, Striberni R.
    Clin Pharmacol Ther; 1989 Jan 01; 45(1):34-40. PubMed ID: 2910636
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polymorphism of dextromethorphan oxidation in a French population.
    Larrey D, Amouyal G, Tinel M, Letteron P, Berson A, Labbe G, Pessayre D.
    Br J Clin Pharmacol; 1987 Nov 01; 24(5):676-9. PubMed ID: 3435696
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.